Lifesaving liver disease medicines




Our mission

Versantis develops a new generation of liver disease therapeutics and diagnostics.

We are committed to the translation of life-saving therapies for acute hepatic diseases, where the medical need is dramatically high.

A life-saving therapy

Versantis’ lead product candidate, VS-01, is the first treatment for acute-on-chronic liver failure (ACLF), a life-threatening condition of high unmet medical need. The mortality of ACLF patients is alarming due to multi-organ failures resulting in dangerous accumulations of toxins in the blood. The versatile mechanism of action of VS-01 can simultaneously support the affected organs (liver, kidneys, brain), encourage liver regeneration, and save patients’ lives.

discover the full potential of our pipeline...

Awards and supports

GET IN TOUCH

VISIT US

Versantis AG
Technoparkstrasse 1
3rd floor, Newton wing 3007
CH-8005 Zurich
Switzerland

INFO


Copyright © 2018
Versantis AG